questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Troubles hémorragiques
Troubles hémorragiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Temps de prothrombine
Temps de thromboplastine partielle activée
Antécédents familiaux
Hémophilie
Saignement
Évaluation clinique
Symptômes
5
Hémorragie interne
Selles sanglantes
Menstruations
Saignement menstruel
Saignement de nez
Troubles hémorragiques
Prévention
5
Prévention
Gestion des risques
Mode de vie
Alimentation équilibrée
Activités sportives
Prévention des blessures
Consultation médicale
Suivi médical
Traitements
5
Transfusion sanguine
Thérapie génique
Hémophilie
Facteurs de coagulation
Anticoagulants
Saignement
Classification des maladies
Traitement
Complications
5
Hémorragie interne
Choc hypovolémique
Qualité de vie
Soins médicaux
Infections
Transfusion sanguine
Gestion des complications
Traitement
Facteurs de risque
5
Antécédents familiaux
Maladies hépatiques
Troubles menstruels
Femmes
Médicaments
Anticoagulants
Maladies auto-immunes
Coagulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles hémorragiques : Questions médicales les plus fréquentes",
"headline": "Troubles hémorragiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles hémorragiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-25",
"dateModified": "2025-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles hémorragiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémopathies",
"url": "https://questionsmedicales.fr/mesh/D006402",
"about": {
"@type": "MedicalCondition",
"name": "Hémopathies",
"code": {
"@type": "MedicalCode",
"code": "D006402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Troubles de l'hémostase",
"alternateName": "Hemostatic Disorders",
"url": "https://questionsmedicales.fr/mesh/D020141",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de l'hémostase",
"code": {
"@type": "MedicalCode",
"code": "D020141",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémangiome caverneux",
"alternateName": "Hemangioma, Cavernous",
"url": "https://questionsmedicales.fr/mesh/D006392",
"about": {
"@type": "MedicalCondition",
"name": "Hémangiome caverneux",
"code": {
"@type": "MedicalCode",
"code": "D006392",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Réaction de Schwartzman",
"alternateName": "Shwartzman Phenomenon",
"url": "https://questionsmedicales.fr/mesh/D012790",
"about": {
"@type": "MedicalCondition",
"name": "Réaction de Schwartzman",
"code": {
"@type": "MedicalCode",
"code": "D012790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515.810"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie du pool vide",
"alternateName": "Platelet Storage Pool Deficiency",
"url": "https://questionsmedicales.fr/mesh/D010981",
"about": {
"@type": "MedicalCondition",
"name": "Maladie du pool vide",
"code": {
"@type": "MedicalCode",
"code": "D010981",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombocytémie essentielle",
"alternateName": "Thrombocythemia, Essential",
"url": "https://questionsmedicales.fr/mesh/D013920",
"about": {
"@type": "MedicalCondition",
"name": "Thrombocytémie essentielle",
"code": {
"@type": "MedicalCode",
"code": "D013920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.825"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles hémorragiques",
"alternateName": "Hemorrhagic Disorders",
"code": {
"@type": "MedicalCode",
"code": "D006474",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Avrey Thau",
"url": "https://questionsmedicales.fr/author/Avrey%20Thau",
"affiliation": {
"@type": "Organization",
"name": "Thomas Jefferson University, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "Brooke Saffren",
"url": "https://questionsmedicales.fr/author/Brooke%20Saffren",
"affiliation": {
"@type": "Organization",
"name": "Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "James D Anderst",
"url": "https://questionsmedicales.fr/author/James%20D%20Anderst",
"affiliation": {
"@type": "Organization",
"name": "Division of Child Adversity and Resilience, Children's Mercy Hospital, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Shannon L Carpenter",
"url": "https://questionsmedicales.fr/author/Shannon%20L%20Carpenter",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematology, Oncology, and Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Thibault Coste",
"url": "https://questionsmedicales.fr/author/Thibault%20Coste",
"affiliation": {
"@type": "Organization",
"name": "AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36546488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/phcfm.v14i1.3736"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35964881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.08.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate organogenesis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35726824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.200394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles hémorragiques",
"item": "https://questionsmedicales.fr/mesh/D006474"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles hémorragiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles hémorragiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles hémorragiques",
"description": "Comment diagnostiquer un trouble hémorragique ?\nQuels tests sont utilisés pour évaluer la coagulation ?\nLes antécédents familiaux sont-ils importants ?\nComment évaluer la gravité d'un saignement ?\nLes examens d'imagerie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles hémorragiques",
"description": "Quels sont les symptômes courants des troubles hémorragiques ?\nComment reconnaître une hémorragie interne ?\nLes saignements menstruels peuvent-ils indiquer un trouble ?\nQuelles sont les manifestations cutanées des troubles hémorragiques ?\nLes saignements de nez sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles hémorragiques",
"description": "Comment prévenir les troubles hémorragiques ?\nLes vaccinations sont-elles importantes ?\nLe mode de vie influence-t-il ces troubles ?\nLes activités sportives doivent-elles être évitées ?\nLes consultations médicales régulières sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles hémorragiques",
"description": "Quels traitements sont disponibles pour les troubles hémorragiques ?\nComment traiter l'hémophilie ?\nLes anticoagulants sont-ils utilisés dans ces troubles ?\nQuelles sont les options pour les saignements sévères ?\nLes traitements varient-ils selon le type de trouble ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles hémorragiques",
"description": "Quelles complications peuvent survenir ?\nLes troubles hémorragiques peuvent-ils être mortels ?\nComment les troubles hémorragiques affectent-ils la qualité de vie ?\nLes troubles hémorragiques augmentent-ils le risque d'infections ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles hémorragiques",
"description": "Quels sont les facteurs de risque des troubles hémorragiques ?\nL'âge influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLes maladies auto-immunes sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble hémorragique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des antécédents médicaux, des tests de coagulation et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la coagulation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests courants incluent le temps de prothrombine (TP) et le temps de thromboplastine partielle activée (TTPa)."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles hémorragiques peuvent indiquer une prédisposition génétique."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité d'un saignement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par la quantité de sang perdu et l'impact sur la santé générale du patient."
}
},
{
"@type": "Question",
"name": "Les examens d'imagerie sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Parfois, des examens d'imagerie comme l'échographie peuvent être nécessaires pour détecter des hématomes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles hémorragiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des saignements fréquents, des ecchymoses, et des saignements des gencives."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs abdominales, des vertiges, et des selles noires ou sanglantes."
}
},
{
"@type": "Question",
"name": "Les saignements menstruels peuvent-ils indiquer un trouble ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des menstruations excessives peuvent signaler un trouble hémorragique sous-jacent."
}
},
{
"@type": "Question",
"name": "Quelles sont les manifestations cutanées des troubles hémorragiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ecchymoses, des pétéchies et des saignements sous-cutanés peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les saignements de nez sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les saignements de nez récurrents peuvent être un symptôme de troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles hémorragiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un diagnostic précoce, une gestion des facteurs de risque et des soins appropriés."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections qui aggravent les troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une alimentation équilibrée, peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les activités sportives doivent-elles être évitées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités à risque doivent être évitées pour prévenir les blessures et les saignements."
}
},
{
"@type": "Question",
"name": "Les consultations médicales régulières sont-elles nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations régulières aident à surveiller et à gérer les troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles hémorragiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des transfusions sanguines, des médicaments et des thérapies géniques."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hémophilie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémophilie est traitée par des facteurs de coagulation administrés par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils utilisés dans ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les anticoagulants peuvent aggraver les saignements et ne sont pas recommandés."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour les saignements sévères ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments hémostatiques et, dans certains cas, une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de trouble ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend du type spécifique de trouble hémorragique et de sa gravité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies internes, des chocs hypovolémiques et des infections."
}
},
{
"@type": "Question",
"name": "Les troubles hémorragiques peuvent-ils être mortels ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements non contrôlés peuvent entraîner des complications graves et potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Comment les troubles hémorragiques affectent-ils la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes et nécessiter des soins médicaux fréquents."
}
},
{
"@type": "Question",
"name": "Les troubles hémorragiques augmentent-ils le risque d'infections ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme les transfusions peuvent augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une gestion proactive et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles hémorragiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies hépatiques et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles hémorragiques augmente avec l'âge en raison de la dégradation des fonctions corporelles."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions, comme les troubles menstruels, peuvent augmenter le risque chez les femmes."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les anticoagulants, peuvent augmenter le risque de saignement."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter la coagulation et augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 19/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Thomas Jefferson University, Philadelphia, PA, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Division of Child Adversity and Resilience, Children's Mercy Hospital, Kansas City, MO, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, Oncology, and Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, MO, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Université de Paris, INSERM UMR-1141 Neurodiderot, Paris, France.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Université de Paris, INSERM UMR-1141 Neurodiderot, Paris, France.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, ChristianaCare, Newark, Delaware.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy. sergiobagnato@gmail.com.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Molecular Biology Laboratory, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Cardinal Ferrari Center, Fontanellato, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
RAN (Research in Advanced Neuro-Rehabilitation), S. Anna Institute, Crotone, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Neurorehabilitation and Spinal Units, ICS Maugeri, Institute of Pavia, Pavia, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Montecatone Rehabilitation Institute, Imola, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Clinical Pathology Laboratory, Provincial Health Authority of Caltanissetta, Caltanissetta, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Department of Ophthalmology, Hallym University Dongtan Sacred Heart Hospital, Hallym University Medical Center, Hwaseong-si, Gyeonggi-do, Republic of Korea.
Publications dans "Troubles hémorragiques" :
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...